Review the side-effects of Necitumumab as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the instances these side-effects are mild and easily tolerable, however sometimes they can be more severe and can be detrimental.
If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist.
Gastrointestinal: Nausea, vomiting, mouth ulcers, pain and swelling of the digestive tract, difficulty in swallowing
Respiratory: Coughing up blood, breathing difficulty, blood clots in lungs
Skin: Rashes, itching, dry skin, pimples, cracks in the skin
Eye: Irritation and itching of the eye, pain, blurred vision, increased tear secretion
Lab abnormalities: Low levels of magnesium, potassium, calcium, and phosphate
Others: Pulmonary embolism, cerebral stroke, heart attack, headache, weight loss
• Breastfeeding should be stopped during the necitumumab treatment and for three months after stopping to take necitumumab.
If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist.
Gastrointestinal: Nausea, vomiting, mouth ulcers, pain and swelling of the digestive tract, difficulty in swallowing
Respiratory: Coughing up blood, breathing difficulty, blood clots in lungs
Skin: Rashes, itching, dry skin, pimples, cracks in the skin
Eye: Irritation and itching of the eye, pain, blurred vision, increased tear secretion
Lab abnormalities: Low levels of magnesium, potassium, calcium, and phosphate
Others: Pulmonary embolism, cerebral stroke, heart attack, headache, weight loss
Other Precautions :
• Females of reproductive potential living with active male partners should use effective contraception during the treatment with necitumumab and must continue the contraception for at least three months after the last dose of necitumumab.• Breastfeeding should be stopped during the necitumumab treatment and for three months after stopping to take necitumumab.
